JM

Jonathan Milner

North America, Massachusetts, United States, Cambridge

Description

Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for sup...

Investor Profile

Jonathan Milner has made 55 investments, with 11 in the past 12 months and 20% as lead.

Stage Focus

  • Seed (40%)
  • Series A (24%)
  • Series B (16%)
  • Series C (9%)
  • Series Unknown (9%)
  • Angel (2%)

Country Focus

  • United Kingdom (95%)
  • United States (2%)
  • Canada (2%)
  • Spain (2%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Life Science
  • Biopharma
  • Artificial Intelligence (Ai)
  • Pharmaceutical
  • Genetics
  • Health Diagnostics
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Jonathan Milner frequently co-invest with?

UK Innovation & Science Seed Fund
Europe, Oxfordshire, United Kingdom, Harwell
Co-Investments: 4
Cambridge Innovation Capital
Europe, Cambridgeshire, United Kingdom, Cambridge
Co-Investments: 5
Astellas Venture Management
North America, California, United States, Menlo Park
Co-Investments: 4
Cambridge Angels group
Europe, England, United Kingdom, London
Co-Investments: 4
Amadeus Capital Partners
Europe, Cambridgeshire, United Kingdom, Cambridge
Co-Investments: 8
O2h Ventures
Europe, Cambridgeshire, United Kingdom, Hauxton
Co-Investments: 6
University of Cambridge Enterprise
Europe, Cambridgeshire, United Kingdom, Cambridge
Co-Investments: 6
Balderton Capital
Europe, England, United Kingdom, London
Co-Investments: 3
IQ Capital
Europe, Cambridgeshire, United Kingdom, Cambridge
Co-Investments: 3
Parkwalk Advisors
Europe, England, United Kingdom, London
Co-Investments: 12

Which angels does Jonathan Milner often collaborate with?

DD
Europe, Cambridgeshire, United Kingdom, Cambridge
Shared Deals: 4
David Evans
Oceania, New South Wales, Australia, Sydney
Shared Deals: 2
AC
Europe, England, United Kingdom, London
Shared Deals: 1
Shared Deals: 1
TD
Europe, Denmark
Shared Deals: 1
PN
Europe, Hovedstaden, Denmark, Copenhagen
Shared Deals: 1
HG
North America, Missouri, United States, Saint Louis
Shared Deals: 1
JT
Europe, England, United Kingdom, London
Shared Deals: 1
CC
Europe, Lombardia, Italy, Milan
Shared Deals: 1
LZ
Europe, England, United Kingdom, London
Shared Deals: 1

What are some of recent deals done by Jonathan Milner?

Quibim

Valencia, Comunidad Valenciana, Spain

Quibim is a radiomics company specializing in quantitative imaging of biomarkers and medical applications in precision medicine.

Artificial Intelligence (AI)BiotechnologyClinical TrialsHealth CareHealth Diagnostics
Series AJan 28, 2025
Amount Raised: $50,000,000
52 North Health

Cambridge, Cambridgeshire, United Kingdom

52 North Health is developing a fully-integrated clinical, AI-driven medical device-based system called NeutroCheck for people with cancer.

Artificial Intelligence (AI)Health CareMedical
Series UnknownDec 3, 2024
Amount Raised: $6,000,000
Exciting Instruments

Sheffield, Sheffield, United Kingdom

Exciting Instruments Limited is a joint company that combines the software prowess.

ElectronicsIndustrial ManufacturingSoftware
SeedNov 25, 2024
Amount Raised: $5,015,680
Epitopea

Cambridge, Cambridgeshire, United Kingdom

Epitopea is a transatlantic cancer immunotherapeutics company.

BiotechnologyLife ScienceTherapeutics
SeedOct 24, 2024
Amount Raised: $31,000,000
Nuclera

Cambridge, Cambridgeshire, United Kingdom

Nuclera offers a protein prototyping system to accelerate drug discovery by making proteins readily available to researchers.

BiotechnologyLife SciencePharmaceutical
Series COct 15, 2024
Amount Raised: $75,000,000
Shift Bioscience

Cambridge, Cambridgeshire, United Kingdom

Simulation guided target discovery for age-linked diseases

BiopharmaBiotechnologyMachine LearningPharmaceutical
SeedOct 15, 2024
Amount Raised: $16,331,095
Clock Bio

Cambridge, Cambridgeshire, United Kingdom

Clock Bio operates as a biotech company.

BiotechnologyMedical
SeedOct 9, 2024
Amount Raised: $5,300,000
Constructive Bio

Cambridge, Cambridgeshire, United Kingdom

At Constructive Bio we rewrite genomes to build the biomolecules of the future.

Biotechnology
Series ASep 24, 2024
Amount Raised: $57,735,480
LIfT BioSciences

London, England, United Kingdom

LIfT Biosciences® a rapidly emerging biotech company bringing to market a first-in-class allogeneic innate cell therapy

BiopharmaBiotechnologyHealth CareLife ScienceMedicalOncologyPharmaceutical
Series ASep 24, 2024
Amount Raised: $13,426,856
PhoreMost

Cambridge, Cambridgeshire, United Kingdom

PhoreMost is a new-model drug discovery company based in Cambridge, UK.

BiopharmaBiotechnologyHealth Care
Series BSep 12, 2024
Amount Raised: $12,000,000